0010B |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Blood |
0010SP |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Serum/Plasma |
0010U |
2-fluoro Deschloroketamine and Deschloroketamine (Qualitative), Urine |
0014B |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Blood |
0014SP |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Serum/Plasma |
0014U |
3-MeO-PCP and 3-hydroxy-PCP (Qualitative), Urine |
0015B |
2-methyl AP-237 & AP-238, Blood |
0015SP |
2-methyl AP-237 & AP-238, Serum/Plasma |
0015U |
2-methyl AP-237 & AP-238, Urine |
0205B |
Acetyl Fentanyl, Blood |
0205SP |
Acetyl Fentanyl, Serum/Plasma |
0205U |
Acetyl Fentanyl and Metabolite, Urine |
0570B |
Designer Benzodiazepines, Blood |
0570SP |
Designer Benzodiazepines, Serum/Plasma |
0570U |
Designer Benzodiazepines (Qualitative), Urine |
0771B |
Brorphine, Blood |
0771SP |
Brorphine, Serum/Plasma |
0771U |
Brorphine, Urine |
1021B |
Substituted Cathinone Panel, Blood |
1021SP |
Substituted Cathinone Panel, Serum/Plasma |
1021U |
Substituted Cathinone Panel, Urine |
1022B |
Eutylone, Blood |
1022SP |
Eutylone, Serum/Plasma |
1022U |
Eutylone (Qualitative), Urine |
1030B |
Carisoprodol and Metabolite, Blood |
1030FL |
Carisoprodol and Metabolite, Fluid |
1030SP |
Carisoprodol and Metabolite, Serum/Plasma |
1030U |
Carisoprodol and Metabolite, Urine |
1255B |
Chlorzoxazone, Blood |
1255SP |
Chlorzoxazone, Serum/Plasma |
1405B |
Cyclobenzaprine, Blood |
1405FL |
Cyclobenzaprine, Fluid |
1405SP |
Cyclobenzaprine, Serum/Plasma |
1405TI |
Cyclobenzaprine, Tissue |
1405U |
Cyclobenzaprine, Urine |
1439SP |
Dantrolene, Serum/Plasma |
1480B |
Designer Opioids, Blood |
1480SP |
Designer Opioids, Serum/Plasma |
1480U |
Designer Opioids (Qualitative), Urine |
1483B |
Desalkylgidazepam, Blood |
1483SP |
Desalkylgidazepam, Serum/Plasma |
1483U |
Desalkylgidazepam (Qualitative), Urine |
2111B |
Baclofen, Blood |
2111FL |
Baclofen, Fluid |
2111SP |
Baclofen, Serum/Plasma |
2111TI |
Baclofen, Tissue |
2111U |
Baclofen, Urine |
2626B |
Bath Salts Panel (Qualitative), Blood |
2626SP |
Bath Salts Panel (Qualitative), Serum/Plasma |
2626U |
Bath Salts Panel (Qualitative), Urine |
2720B |
Metaxalone, Blood |
2720SP |
Metaxalone, Serum/Plasma |
2720U |
Metaxalone, Urine |
2900B |
Methocarbamol, Blood |
2900FL |
Methocarbamol, Fluid |
2900SP |
Methocarbamol, Serum/Plasma |
3064B |
Mitragynine, Blood |
3064SP |
Mitragynine, Serum/Plasma |
3078U |
Mitragynine (Qualitative), Urine |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
3248B |
Orphenadrine, Blood |
3248SP |
Orphenadrine, Serum/Plasma |
3248U |
Orphenadrine, Urine |
4047B |
Pyrrolidinophenone Panel, Blood |
4047SP |
Pyrrolidinophenone Panel, Serum/Plasma |
4282SP |
Synthetic Cannabinoids (Qualitative), Serum/Plasma |
4283U |
Synthetic Cannabinoid Metabolites-Expanded (Qualitative), Urine |
4487B |
Tizanidine, Blood |
4487SP |
Tizanidine, Serum/Plasma |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9105B |
Acetyl Fentanyl Screen, Blood |
9105SP |
Acetyl Fentanyl Screen, Serum/Plasma |
9105U |
Acetyl Fentanyl Screen, Urine |
9129B |
Carisoprodol and Metabolite Screen, Blood |
9129FL |
Carisoprodol and Metabolite Screen, Fluid |
9129SP |
Carisoprodol and Metabolite Screen, Serum/Plasma |
9219B |
Orphenadrine Screen, Blood |
9560B |
Synthetic Cannabinoids Screen, Blood |
9562U |
Synthetic Cannabinoid Metabolites Screen - Expanded, Urine |